YU93902A - Postupak za pripremanje pirazolopirimidinona - Google Patents

Postupak za pripremanje pirazolopirimidinona

Info

Publication number
YU93902A
YU93902A YU93902A YUP93902A YU93902A YU 93902 A YU93902 A YU 93902A YU 93902 A YU93902 A YU 93902A YU P93902 A YUP93902 A YU P93902A YU 93902 A YU93902 A YU 93902A
Authority
YU
Yugoslavia
Prior art keywords
compound
pyrazolopyrimidinones
preparation
general formula
formula
Prior art date
Application number
YU93902A
Other languages
English (en)
Inventor
Peter James Dunn
Catherine Dunne
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26244540&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU93902(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0015472A external-priority patent/GB0015472D0/en
Priority claimed from GB0105857A external-priority patent/GB0105857D0/en
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU93902A publication Critical patent/YU93902A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Ostvaren je postupak za proizvodnju jednog jedinjenja opšte formule (I) u kome A, A1, R2 i R4 imaju značenja data u opisu, a koji postupak obuhvata reagovanje jednog jedinjenja formule (II), u kome je Rx jedna grupa koja se može zameniti jednim aminopirazolom, sa jednim jedinjenjem opšte formule (III).[There is provided a process for the production of a compound of general formula (I) wherein A, A1, R2, R3 and R4 have meansings given in the description, which process comprises the reaction of a compound of formula (II), wherein Rx is a group substitutable by an aminopyrazole, with a compound of general formula (III).
YU93902A 2000-06-22 2001-06-11 Postupak za pripremanje pirazolopirimidinona YU93902A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0015472A GB0015472D0 (en) 2000-06-22 2000-06-22 Novel process for the preparation of pyrazolopyrimidinones
GB0105857A GB0105857D0 (en) 2001-03-09 2001-03-09 Novel process for the preparation of pyrazolopyrimidinones

Publications (1)

Publication Number Publication Date
YU93902A true YU93902A (sh) 2005-11-28

Family

ID=26244540

Family Applications (1)

Application Number Title Priority Date Filing Date
YU93902A YU93902A (sh) 2000-06-22 2001-06-11 Postupak za pripremanje pirazolopirimidinona

Country Status (28)

Country Link
EP (1) EP1292586B1 (sh)
JP (1) JP2004501142A (sh)
KR (1) KR100525698B1 (sh)
CN (1) CN100338047C (sh)
AP (1) AP2001002194A0 (sh)
AR (1) AR028740A1 (sh)
AT (1) ATE272626T1 (sh)
AU (2) AU2001262597B2 (sh)
BR (1) BR0111581A (sh)
CA (1) CA2411961C (sh)
CZ (1) CZ20024176A3 (sh)
DE (1) DE60104691T2 (sh)
DK (1) DK1292586T3 (sh)
DO (1) DOP2001000190A (sh)
ES (1) ES2223863T3 (sh)
HU (1) HUP0301183A3 (sh)
IL (1) IL153532A0 (sh)
MX (1) MXPA02012884A (sh)
MY (1) MY124903A (sh)
PA (1) PA8519801A1 (sh)
PE (1) PE20020105A1 (sh)
PL (1) PL359651A1 (sh)
PT (1) PT1292586E (sh)
SV (1) SV2002000503A (sh)
TN (1) TNSN01093A1 (sh)
TR (1) TR200401983T4 (sh)
WO (1) WO2001098284A1 (sh)
YU (1) YU93902A (sh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2310144B1 (es) 2007-06-15 2010-01-12 Galenicum Health, S.L. Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5.
WO2009082845A1 (fr) * 2007-12-28 2009-07-09 Topharman Shanghai Co., Ltd. N-{1-[3-(2-éthoxy-5-(4-éthylpipérazinyl)benzènesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]éthyl}butyramide, son procédé de préparation et son utilisation
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
AU2010280358A1 (en) 2009-08-07 2012-03-08 Ranbaxy Laboratories Limited Processes for the preparation of vardenafil
EP2523664A4 (en) * 2010-01-13 2013-06-26 Tempero Pharmaceuticals Inc COMPOUNDS AND METHODS
MX2010006227A (es) 2010-06-07 2011-12-14 World Trade Imp Exp Wtie Ag Nuevos derivados 1,4-diazepanos, inhibidores de pde-5.
FR2970967B1 (fr) 2011-01-27 2013-02-15 Pf Medicament Derives de type azaindazole ou diazaindazole comme medicament
EP2689778A1 (en) 2012-07-27 2014-01-29 Pierre Fabre Medicament Derivatives of azaindoles or diazaindoles for treating pain
EP2689779A1 (en) 2012-07-27 2014-01-29 Pierre Fabre Medicament Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk
EP3529246B1 (en) * 2016-10-24 2023-10-18 FMC Corporation Oxadiazoles having fungicidal activity
CA3112921A1 (en) * 2018-10-01 2020-04-09 Pi Industries Ltd. Novel oxadiazoles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822238D0 (en) * 1998-10-12 1998-12-09 Pfizer Ltd Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof
EP1002798A1 (en) * 1998-11-20 2000-05-24 Orchid Chemicals & Pharmaceuticals Ltd. An improved process for preparing a therapeutically active pyrazolopyrimidinone derivative

Also Published As

Publication number Publication date
KR100525698B1 (ko) 2005-11-03
TNSN01093A1 (fr) 2005-11-10
MXPA02012884A (es) 2003-05-14
DE60104691D1 (de) 2004-09-09
MY124903A (en) 2006-07-31
SV2002000503A (es) 2002-07-03
BR0111581A (pt) 2003-03-25
CN100338047C (zh) 2007-09-19
PT1292586E (pt) 2004-11-30
HUP0301183A2 (hu) 2003-08-28
CN1437589A (zh) 2003-08-20
EP1292586B1 (en) 2004-08-04
KR20030031912A (ko) 2003-04-23
AR028740A1 (es) 2003-05-21
WO2001098284A1 (en) 2001-12-27
CA2411961C (en) 2007-02-06
AU6259701A (en) 2002-01-02
DE60104691T2 (de) 2005-01-13
HK1054926A1 (en) 2003-12-19
AP2001002194A0 (en) 2002-12-21
ES2223863T3 (es) 2005-03-01
TR200401983T4 (tr) 2004-09-21
ATE272626T1 (de) 2004-08-15
DK1292586T3 (da) 2004-08-30
EP1292586A1 (en) 2003-03-19
CZ20024176A3 (cs) 2004-01-14
IL153532A0 (en) 2003-07-06
PL359651A1 (en) 2004-08-23
AU2001262597B2 (en) 2005-10-20
PE20020105A1 (es) 2002-02-21
JP2004501142A (ja) 2004-01-15
HUP0301183A3 (en) 2006-02-28
PA8519801A1 (es) 2002-04-25
CA2411961A1 (en) 2001-12-27
DOP2001000190A (es) 2002-05-15

Similar Documents

Publication Publication Date Title
TW200738672A (en) Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
GEP20053541B (en) Pyrrolo[2,3-d]Pyrimidine Compounds
NZ525398A (en) Phase transfer catalyzed glycosidation of an indolocarbazole
AP2001002194A0 (en) Novel process for the preparation of pyrazolopyrimidinones.
PL368722A1 (en) Processes for the manufacturing of 3-hydroxy-n,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
WO2002016322A3 (en) Process for the preparation of 2-aminoethylpyridines
CA2394439A1 (en) Process for the preparation of a pyridinemethanol compound
IL156141A0 (en) A process for the preparation of taxan derivatives
GB9907458D0 (en) Processes for preparing pesticidal intermediates
AU8459401A (en) Process for preparing a substituted imidazopyridine compound
AU2003224115A1 (en) A process for the preparation of clopidogrel
SI1172364T1 (en) A process for the preparation of 2-phenyl-imidazo(1,2-A)pyridine-3-acetamides
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
EP1092720A3 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
AP2001002195A0 (en) Novel process for the preparation of pyrazolopyrimidinones.
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
HK1049836A1 (zh) 新的偶合方法
MXPA04004708A (es) Proceso para preparacion de 2- o 9-oxa-3,7-diazabiciclo (3.3.1)nonanos a partir de 2-aminometil-2,3-dihidrooxazinas, compuestos intermedios para los mismos y proceso para preparar tales compuestos intermedios.
UY26784A1 (es) Nuevo procedimiento para la preparación de pirazolopirimidinonas
IL133815A0 (en) Process for the preparation of 2-alkylthiobenzonitrile derivatives
AU2001253602A1 (en) Synthesis of intermediates useful in preparing tricyclic compounds
MXPA03000917A (es) Procedimiento para la preparacion de 9,10-dihidropirrolo (2,1-b)(1,3)benzotiazepinas sustituidas con 9-amino.
AP2000001960A0 (en) Process for the preparation of pyrazole(4,3-d)pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof.
MX9704411A (es) Compuestos triciclicos.